49 results
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
or natural disasters or any pandemic or epidemic, including COVID-19, (vi) any action taken or omitted to be taken by the Company at the written request
8-K
RYTM
Rhythm Pharmaceuticals Inc.
4 Jan 24
Entry into a Material Definitive Agreement
7:00am
, the Company’s ability to hire and retain necessary personnel, the impact of the COVID-19 pandemic and general economic conditions on the Company’s
8-K
RYTM
Rhythm Pharmaceuticals Inc.
6 Dec 23
Other Events
4:30pm
, risks relating to intellectual property, the Company’s ability to hire and retain necessary personnel, the impact of the COVID-19 pandemic
8-K
EX-99.1
uz4hi8ah
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
8-K
6sw3kdq6t4lowi
21 Aug 23
Other Events
4:30pm
8-K
EX-99.1
b7s14gv0
1 Aug 23
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business
7:05am
8-K
EX-99.1
1t8p3e9ywf
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
talk48clfvv3qhufw
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am
8-K
f9fcxb9
3 Nov 22
Termination of a Material Definitive Agreement
4:55pm
424B5
t5cyp xu60zwne8r
15 Sep 22
Prospectus supplement for primary offering
4:00pm
424B5
pcs126s qvynrgwfe
14 Sep 22
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
4t3m tf60rk5c8
2 Aug 22
Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update
7:02am